10% Revenue Growth, Promising Pipeline for Pharmaceutical Company of the Year

Med Ad News and PharmaLive.com have identified the top-performing pharmaceutical companies of the year. Roche has been acknowledged as Pharmaceutical Company of the Year. The company’s total sales grew 10% in 2009 to $45.17 billion, with the Pharmaceutical and Diagnostics divisions accounting for 80% and 20% of company sales respectively. These divisions both grew twice as fast as their respective markets. Roche expects strong 2010 sales as well. In the first half of 2010, the Pharmaceutical division filed nine major new marketing applications and gained 11 major approvals. As of the end of June, the division’s clinical development portfolio included 60 new molecular entities and 42 additional indications. Roche’s late-stage pipeline comprises potential first-in-class or best-in-class medicines in the areas of cancer, metabolic and autoimmune diseases, and CNS disorders.

Top 50 Pharmaceutical Companies & Their Pipelines 2010, PharmaLive’s newest Special Report, examines the top-performing pharmaceutical companies, their drugs in development, and the corporate strategies that are driving growth. 

The U.S. remains the world’s leading pharma market with a 40% share while Europe holds 28% of the global market. 2009 sales in the U.S. and Europe grew 29% and 17% respectively over 2008 sales. Emerging markets continue to exhibit high growth, with 2009 sales increasing 35% above 2008.

“Roche has strategically positioned itself for continuing success with the acquisition of Genentech,” says Andrew Humphreys, editor in chief of Canon Data Products Group. “Strategies for early-stage and late-stage drugs, a strong pipeline, and capabilities of pharmaceutical and diagnostic R&D centers support Roche for sustainable, long-term growth.”

More information is available in PharmaLive’s most recent Special Report, Top 50 Pharmaceutical Companies & Their Pipelines 2010, including qualitative and expert analysis of the strategies being employed by successful pharma companies, drugs in development and key therapeutic categories for each of the top-performing companies, as well as challenges and opportunities on the horizon. This report can be found at www.PharmaLive.com/specialreports.


About Canon Data Products Group

Canon Data Products Group, a division of Canon Communications LLC, publishes PharmaLive Special Reports and Appliance Market Research Reports, which provide financial, company, and product statistical data and qualitative analysis for the global pharmaceutical, biotechnology, medical device, and appliance industries; maintains eKnowledgeBase and MDRWeb, comprehensive market intelligence tools serving the pharmaceutical, biotechnology, and medical-device sectors; and manages company-wide Site Licenses for PharmaLive.com, Med Ad News, and R&D Directions.

 

Please direct all media inquiries to:

Sandra Baker

215-944-9836

Sandra.baker@cancom.com

 

Your rating: None Average: 5 (1 vote)